1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Clarity Pharmaceuticals Limited has 1 pending office action. The prosecution involves a distinct examiner and 0 distinct art units, which indicates the matter has not yet been assigned to a specific art unit.
PERREIRA, MELISSA JEAN is the busiest examiner, assigned 1 pending office action. This examiner handles the total pending volume for the company, representing the point of contact for the current pending matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PERREIRA, MELISSA JEAN | 1 | 52.1% | +25.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18339124 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | PERREIRA, MELISSA JEAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18339124 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | PERREIRA, MELISSA JEAN | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18339124 | FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING | PERREIRA, MELISSA JEAN | — | §103§112Other | Non-Final OA | — | Pending | Jun 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialClarity Pharmaceuticals Limited has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Melissa Jean Perreira has the most, with 1 of Clarity Pharmaceuticals Limited's pending office actions.
